SenoGuard

Non-Radiation Breakthrough in Breast Cancer Treatment

https://wefunder.com/senoguard.inc

Total raised on Wefunder: 54400

Total investors: 22

Quick facts

  • An alternative to radiation after lumpectomy that avoids pain, fatigue,clinical and cosmetic damage.
  • $1.2M from National Science Foundation: proved effectiveness. 2nd grant awarded to do FDA submission
  • Affordable & accessible, avoids RT toxicities, offers a better option. Done at time of lumpectomy
  • Experienced team with 100+ years in advancing women's healthcare with innovative medical devices.
  • Eliminates up to 6 weeks of daily treatments at radiation center that may require long distances
  • Allows proper treatment for 28% of patients unable to get RT due to distance, cost, or no time off.
  • Allows breast cancer treatment to be done at community hospitals where most women prefer treatment.
  • Allows lumpectomy to be performed globally in countries where mastectomy is currently only choice

Team profiles

Featured investor profiles

Invest in SenoGuard

Non-Radiation Breakthrough in Breast Cancer Treatment

FIRST GOAL HIT (You can still invest)

$56,500

raised from 28 investors
INVESTMENT TERMS
Future Equity
$5M valuation cap 20% discount

What Investors Say

LEAD INVESTOR
Invested $5,000 this round
We are motivated to invest in SenoGuard by the potential for being part of the next advance in early-stage breast cancer treatment. Giving women the option of a one-time freezing treatment post lumpectomy vs. weeks of damaging irradiation seems like a much better option to us. In addition, expanding treatment options for breast cancer patients who may not have access to or be able to afford current treatment is important. The fact that this technology has the backing of two National Science Foundation (NSF) grants, is impressive. Along with the NSF, we think the SenoGuard technology should be explored further and we look forward to our investment being used to help women with breast cancer suffer less.
What People Say